QuidelOrtho - QDEL Stock Forecast, Price & News

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for QuidelOrtho in the last year. There are currently 2 hold ratings, 2 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" QDEL shares.
View QDEL analyst ratings or view top-rated stocks.

5 Wall Street research analysts have issued 1 year price objectives for QuidelOrtho's shares. Their QDEL share price forecasts range from $86.00 to $173.00. On average, they expect the company's share price to reach $122.00 in the next year. This suggests a possible upside of 35.2% from the stock's current price.
View analysts price targets for QDEL or view top-rated stocks among Wall Street analysts.

QuidelOrtho's stock was trading at $85.67 on January 1st, 2023. Since then, QDEL stock has increased by 5.3% and is now trading at $90.22.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 15th 2023.
View our QDEL earnings forecast.

QuidelOrtho will be holding an earnings conference call on Wednesday, February 15th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.

QuidelOrtho Co. (NASDAQ:QDEL) released its quarterly earnings results on Thursday, November, 4th. The company reported $5.36 EPS for the quarter, beating the consensus estimate of $3.52 by $1.84. The company had revenue of $509.70 million for the quarter, compared to analysts' expectations of $344.25 million. QuidelOrtho had a net margin of 26.67% and a trailing twelve-month return on equity of 30.18%. The business's quarterly revenue was up 7.1% on a year-over-year basis. During the same period in the prior year, the firm earned $5.68 EPS.

QuidelOrtho updated its FY 2022 earnings guidance on Wednesday, February, 1st. The company provided EPS guidance of for the period. The company issued revenue guidance of $4.04 billion-$4.05 billion, compared to the consensus revenue estimate of $3.23 billion.

47 employees have rated QuidelOrtho Chief Executive Officer Doug Bryant on Glassdoor.com. Doug Bryant has an approval rating of 76% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other QuidelOrtho investors own include NVIDIA (NVDA), DocuSign (DOCU), Tesla (TSLA), PayPal (PYPL), Shopify (SHOP), Block (SQ), Teladoc Health (TDOC), Netflix (NFLX), Advanced Micro Devices (AMD) and Zoom Video Communications (ZM).

QuidelOrtho trades on the NASDAQ under the ticker symbol "QDEL."

QuidelOrtho's stock is owned by a variety of institutional and retail investors. Top institutional investors include LGT Capital Partners LTD. (0.95%), Cannell & Co. (0.35%), New York State Common Retirement Fund (0.25%), Allspring Global Investments Holdings LLC (0.24%), Wedge Capital Management L L P NC (0.23%) and Private Management Group Inc. (0.20%). Insiders that own company stock include Charles P Slacik, Douglas C Bryant, Edward Keith Russell, Edward L Michael, Mary Lake Ph D Polan, Matthew Strobeck, Michael Donald Jr Abney, Randall J Steward, Ratan S Borkar, Robert Joseph Bujarski, Werner Kroll, William J Ferenczy and William J Ferenczy.
View institutional ownership trends.

Shares of QDEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of QDEL stock can currently be purchased for approximately $90.22.

QuidelOrtho (NASDAQ:QDEL) has a market capitalization of $5.96 billion and generates $1.70 billion in revenue each year. The company earns $704.23 million in net income (profit) each year or $18.80 on an earnings per share basis.

The company employs 1,600 workers across the globe.

QuidelOrtho's mailing address is 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA, 92121. The official website for the company is www.quidel.com. The company can be reached via phone at (800) 874-1517, via email at rargueta@quidel.com, or via fax at 858-453-4338.